Jeng Her, PhD

CEO

• Dr. Jeng Her is the founder and CEO of AP Biosciences. He had received a bachelor’s degree in Physics from the National Taiwan University, then turned into biology and earned a Ph.D. degree in Microbiology and Immunology from the University of Virginia in 1993.
• Before setting up AP Biosciences in Taiwan, he had co-founded KaloBios Pharmaceuticals in the Silicon Valley soon after his post-doctoral training at Bristol-Myers Squibb and DNAX Research Institute (now part of Merck). At KaloBios, he co-invented the antibody Humaneering™, a technology which converts non-human antibodies into engineered human-like antibodies with sequences close to the germline to minimize immunogenicity. The technology was then licensed to Novartis non-exclusively for $32M. In 2013, KaloBios went public on NASDAQ with three antibodies in clinical trials, including KB001 for ventilator-associated pneumonia, which was licensed to Sanofi-Pasteur for $270 million.

Jhong-Jhe You, PhD

VP of Antibody Discovery

• Dr. You received his Ph.D. degree on Molecule Medicine from the National Taiwan University, then extended his research in antibody engineering for functionality and stability at the Genomic Research Center, Academia Sinica before joining AP Biosciences.
• In 2013, he joined APBio as the first employee of the company, leading the effort on generation of the human antibody phage display library, Omni-Mab, as well as development of cell-based assay platform for screening & isolation of functional antibodies for immunotherapy. One major task under his scientific and technical leadership is to take antibody discovery through IND-enabling studies for selection of lead candidates into clinical development. In the meantime, he was also responsible for the application and execution of two SBIR (Small Business Innovation Research) grants for development of anti-inflammation biologics.

Spike Lo

VP of Business Development

• Master of Science (Institute of Biochemistry), National Yang Ming University.
• Associate Director of IQVIA RDS Taiwan Ltd.

Eric Tu

Director of Biologics Development

• Ph.D. in Chem Eng, University of California, San Diego.
• Director of Clinical at Gongwin Biopharm Co., Ltd.

Harry Ou

Director of Bioengineering

• Ph.D. in Cancer Biology of UT Southwestern Medical Center.
• Senior Principal Investigator of BeiGene (Taiwan) Limited.

Tony Lin

Director of Accounting & Finance

• Master of Accounting, Georgia State University.
• Former Manager of Provision Co.

Winnie Tseng

Director of Administration

• MBA of Takming University of Science and Technology.
• Former Manager of Fiberpure Co.
• Former Manager of Abnova Co.

Jeff Cheng

Supervisor of Dept. IT

• Bachelor of Science，Ching Kuo Institute of Management and Health.
• Former Company Network Deputy Manage of Fullerton Technology Co.
• Former Information Engineer of Tatung Technology Co.

Kenneth Liu

Supervisor of Dept. Procurement

• Master of Department of Harbor and River Engineering, Taiwan Ocean University.
• Former manager of stem cell pharmaceutical company.

Anna Chiang

Supervisor of Dept. Legal

• Master of Department of Law, National ChengChi University.
• Former manager of LexNovia International IP Law Firm.